65 related articles for article (PubMed ID: 12368171)
21. Multiple inhibitory kinetics reveal an allosteric interplay among thrombin functional sites.
Zavyalova E; Kopylov A
Thromb Res; 2015 Jan; 135(1):212-6. PubMed ID: 25467079
[TBL] [Abstract][Full Text] [Related]
22. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
Dementiev A; Petitou M; Herbert JM; Gettins PG
Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268
[TBL] [Abstract][Full Text] [Related]
23. The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma.
Boström SL; Hansson GF; Sarich TC; Wolzt M
Thromb Res; 2004; 113(1):85-91. PubMed ID: 15081569
[TBL] [Abstract][Full Text] [Related]
24. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
[TBL] [Abstract][Full Text] [Related]
25. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
[TBL] [Abstract][Full Text] [Related]
26. Molecular basis for the inhibition of thrombin by hirudin.
Stone SR; Betz A; Parry MA; Jackman MP; Hofsteenge J
Adv Exp Med Biol; 1993; 340():35-49. PubMed ID: 8154342
[No Abstract] [Full Text] [Related]
27. Crystal structure of thrombin in complex with fibrinogen gamma' peptide.
Pineda AO; Chen ZW; Marino F; Mathews FS; Mosesson MW; Di Cera E
Biophys Chem; 2007 Feb; 125(2-3):556-9. PubMed ID: 16962697
[TBL] [Abstract][Full Text] [Related]
28. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
[TBL] [Abstract][Full Text] [Related]
29. RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.
Jeter ML; Ly LV; Fortenberry YM; Whinna HC; White RR; Rusconi CP; Sullenger BA; Church FC
FEBS Lett; 2004 Jun; 568(1-3):10-4. PubMed ID: 15196911
[TBL] [Abstract][Full Text] [Related]
30. The effect of different anticoagulants on thrombin generation.
Petros S; Siegemund T; Siegemund A; Engelmann L
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):131-7. PubMed ID: 16479195
[TBL] [Abstract][Full Text] [Related]
31. Neutron and X-ray crystallographic analysis of the human α-thrombin-bivalirudin complex at pD 5.0: protonation states and hydration structure of the enzyme-product complex.
Yamada T; Kurihara K; Ohnishi Y; Tamada T; Tomoyori K; Masumi K; Tanaka I; Kuroki R; Niimura N
Biochim Biophys Acta; 2013 Aug; 1834(8):1532-8. PubMed ID: 23712263
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of competitive binding with application to thrombin complexes.
Wedemeyer WJ; Ashton RW; Scheraga HA
Anal Biochem; 1997 May; 248(1):130-40. PubMed ID: 9177732
[TBL] [Abstract][Full Text] [Related]
33. Degradation of rDNA hirudin and alpha-human thrombin hirudin complex in liver and kidney homogenates from rat.
Grötsch H; Hropot M
Thromb Res; 1991 Dec; 64(6):763-7. PubMed ID: 1798966
[No Abstract] [Full Text] [Related]
34. Consequences of the non-specific binding of a protein to a linear polymer: reconciliation of stoichiometric and equilibrium titration data for the thrombin-heparin interaction.
Munro PD; Jackson CM; Winzor DJ
J Theor Biol; 2000 Apr; 203(4):407-18. PubMed ID: 10736217
[TBL] [Abstract][Full Text] [Related]
35. The effect of staphylocoagulase on the subunit structure of human fibrin.
Tager M; King MJ
Thromb Diath Haemorrh; 1974 Mar; 31(1):52-62. PubMed ID: 4836137
[No Abstract] [Full Text] [Related]
36. [Peptides: multiple source of antithrombotic agents].
Thurieau C
Pathol Biol (Paris); 1997 Apr; 45(4):264-7. PubMed ID: 9296073
[No Abstract] [Full Text] [Related]
37. Biochemistry and biology of hirudin.
Toschi V; Lettino M; Gallo R; Badimon JJ; Chesebro JH
Coron Artery Dis; 1996 Jun; 7(6):420-8. PubMed ID: 8889357
[No Abstract] [Full Text] [Related]
38. Technology evaluation: Chrysalin (Orthologic).
Rodgers KE
Curr Opin Mol Ther; 2005 Jun; 7(3):264-72. PubMed ID: 15977425
[TBL] [Abstract][Full Text] [Related]
39. The assay of heparin in thrombin systems.
GODAL HC
Scand J Clin Lab Invest; 1961; 13():153-66. PubMed ID: 13706165
[No Abstract] [Full Text] [Related]
40. [Mathematical models for hyperbolic type of timed dose-response relationship of drugs].
Wang MY; Sun RY
Zhongguo Yao Li Xue Bao; 1987 Nov; 8(6):481-6. PubMed ID: 3451659
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
